Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12852)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shang RZ, Qu SB, Wang DS. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol 2016; 22(45): 9933-9943 [PMID: 28018100 DOI: 10.3748/wjg.v22.i45.9933] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i45/9933.htm |
| Number | Citing Articles |
| 1 |
Ting Zhang, Hong-Wei Gu, Jin-Xing Gao, Yu-Sang Li, He-Bin Tang. Ethanol supernatant extracts of Gynura procumbens could treat nanodiethylnitrosamine-induced mouse liver cancer by interfering with inflammatory factors for the tumor microenvironment. Journal of Ethnopharmacology 2022; 285: 114917 doi: 10.1016/j.jep.2021.114917
|
| 2 |
Zhihong Chen, Yiping Zou, Yuanpeng Zhang, Zhenrong Chen, Fan Wu, Ning Shi, Haosheng Jin. A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2021; 35(11) doi: 10.1002/jcla.24005
|
| 3 |
Gesche K. Gerresheim, Elke Roeb, Audrey M. Michel, Michael Niepmann. Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells 2019; 8(11): 1410 doi: 10.3390/cells8111410
|
| 4 |
Xiao Li, Yize Li, Shuang Bai, Jing Zhang, Zhengcai Liu, Jingyue Yang. NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma. Cancer Management and Research 2021; : 427 doi: 10.2147/CMAR.S266797
|
| 5 |
Giulia Nannini, Gaia Meoni, Leonardo Tenori, Amedeo Amedei. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 4: 69 doi: 10.1007/16833_2023_182
|
| 6 |
Jing An, Huixin He, Weiwei Yao, Yu Shang, Yun Jiang, Zhiqiang Yu. PI3K/Akt/FoxO pathway mediates glycolytic metabolism in HepG2 cells exposed to triclosan (TCS). Environment International 2020; 136: 105428 doi: 10.1016/j.envint.2019.105428
|
| 7 |
Xilong Tang, Jianjin Xue, Jie Zhang, Jiajia Zhou. A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 1907 doi: 10.2147/JHC.S483664
|
| 8 |
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, Tilo Wuensch, Robert Gajowski, Martin Stockmann, David Meierhofer, Hermann‐Georg Holzhütter. Metabolic heterogeneity of human hepatocellular carcinoma: implications for personalized pharmacological treatment. The FEBS Journal 2021; 288(7): 2332 doi: 10.1111/febs.15587
|
| 9 |
Weicheng Wu, Xixi Zheng, Jing Wang, Tianxiao Yang, Wenjuan Dai, Shushu Song, Lan Fang, Yilin Wang, Jianxin Gu. O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0961-7
|
| 10 |
Xiaonuan Luo, Yin Peng, Xinmin Fan, Xiaoxun Xie, Zhe Jin, Xiaojing Zhang. The Crosstalk and Clinical Implications of CircRNAs and Glucose Metabolism in Gastrointestinal Cancers. Cancers 2023; 15(8): 2229 doi: 10.3390/cancers15082229
|
| 11 |
Le Liu, Liping Liang, Genghui Mai, Ye Chen.
A novel fatty acid
metabolism‐related
gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients
. FASEB BioAdvances 2022; 4(9): 585 doi: 10.1096/fba.2022-00017
|
| 12 |
Guizhi Jia, Yan Wang, Chengjie Lin, Shihui Lai, Hongliang Dai, Zhiqian Wang, Luo Dai, Huizhao Su, Yanjie Song, Naiwen Zhang, Yukuan Feng, Bo Tang. RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02090-7
|
| 13 |
Jiaqi Yi, Xuehua Luo, Weijian Huang, Weijun Yang, Yan Qi, Jun He, Huijun Xie. PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma. Oncology Letters 2024; 27(3) doi: 10.3892/ol.2024.14242
|
| 14 |
Ding Li, Yuanyuan Xiong, Muzi Li, Lin Long, Yongjin Zhang, Huifeng Yan, Hua Xiang. STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K/Akt/mTOR pathway. Archives of Biochemistry and Biophysics 2024; 761: 110149 doi: 10.1016/j.abb.2024.110149
|
| 15 |
F Pepe, S Pagotto, S Soliman, C Rossi, P Lanuti, C Braconi, R Mariani-Costantini, R Visone, A Veronese. Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells. Oncogenesis 2017; 6(5): e328 doi: 10.1038/oncsis.2017.35
|
| 16 |
Shuangfeng Li, Shuangshuang Yin, Hui Ding, Yingying Shao, Shiyue Zhou, Weiling Pu, Lifeng Han, Tao Wang, Haiyang Yu. Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention. Cell Proliferation 2023; 56(1) doi: 10.1111/cpr.13346
|
| 17 |
Xuejing Yang, Huijing Feng, Jonghwa Kim, Gang Ti, Lin Wang, Kun Wang, Dong Song. PRR34-AS1 promotes mitochondrial division and glycolytic reprogramming in hepatocellular carcinoma cells through upregulation of MIEF2. Acta Biochimica et Biophysica Sinica 2024; doi: 10.3724/abbs.2024083
|
| 18 |
Abdel-Hady A. Abdel-Wahab, Heba Effat, Engy A. Mahrous, Mennatallah A. Ali, Tamer A. Al-Shafie. A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells . Nutrition and Cancer 2021; 73(6): 1047 doi: 10.1080/01635581.2020.1783329
|
| 19 |
Meetu Rathee, Sheikh Mohammad Umar, Arundhathi J.R. Dev, Akanksha Kashyap, Sandeep R. Mathur, Ajay Gogia, Purusottam Mohapatra, Chandra Prakash Prasad. Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09694-0
|
| 20 |
Wei Li, Ji Hao, Lang Zhang, Zhuo Cheng, Xukun Deng, Guangwen Shu. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo. Journal of Agricultural and Food Chemistry 2017; 65(29): 5961 doi: 10.1021/acs.jafc.7b02120
|
| 21 |
Chunyan Liu, Xiuli Wang, Youzhong Zhang. The Roles of HK2 on Tumorigenesis of Cervical Cancer. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819871306
|
| 22 |
Yanhui Shi, Hongli Yang, Xue Bai, Xiaoyan Liu, Qiang Li, Wenjun Du. Female and diabetes are risk factors for alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II negative in hepatocellular carcinoma. Medicine 2024; 103(42): e40100 doi: 10.1097/MD.0000000000040100
|
| 23 |
Siyuan Wang, Yiling Li, Ning Liu, Wei Shen, Wenhao Xu, Peng Yao, Hongda Liu. Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/8566342
|
| 24 |
Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu. Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma. PeerJ 2020; 8: e9774 doi: 10.7717/peerj.9774
|
| 25 |
Kecai Duan, Kunpeng Fang, Chengjun Sui. TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis. Heliyon 2024; 10(10): e30959 doi: 10.1016/j.heliyon.2024.e30959
|
| 26 |
Yuan-Yuan Chen, Wei-Hua Wang, Lin Che, You Lan, Li-Yin Zhang, Deng-Lin Zhan, Zi-Yan Huang, Zhong-Ning Lin, Yu-Chun Lin. BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming. Cancers 2020; 12(3): 655 doi: 10.3390/cancers12030655
|
| 27 |
Jun Chen, Evan LaGue, Junjie Li, Chendong Yang, Edward P. Hackett, Manuel Mendoza, Jeffry R. Alger, Ralph J. DeBerardinis, Ian R. Corbin, Kelvin L. Billingsley, Jae Mo Park. Profiling Carbohydrate Metabolism in Liver and Hepatocellular Carcinoma with [13C]‐Glycerate Probes. Analysis & Sensing 2021; 1(4): 196 doi: 10.1002/anse.202100034
|
| 28 |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang, Jia-Jie Zhang. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World Journal of Gastroenterology 2021; 27(17): 2025-2038 doi: 10.3748/wjg.v27.i17.2025
|
| 29 |
Weiye Shi, Xu Yao, Xueyu Cao, Yu Fu, Yingze Wang. Serine/Arginine-Rich Splicing Factor 7 Knockdown Inhibits Aerobic Glycolysis and Growth in HepG2 Cells by Regulating PKM2 Expression. Current Issues in Molecular Biology 2024; 46(5): 5023 doi: 10.3390/cimb46050301
|
| 30 |
Suzan Attia Mawed, Yan He, Jin Zhang, Jie Mei. Strategy of Hepatic Metabolic Defects Induced by beclin1 Heterozygosity in Adult Zebrafish. International Journal of Molecular Sciences 2020; 21(4): 1533 doi: 10.3390/ijms21041533
|
| 31 |
Hiroyuki Hachiya, Taku Aoki, Yukihiro Iso, Takayuki Shimizu, Kazuma Tago, Kyung Hwa Park, Yuhki Sakuraoka, Takayuki Shiraki, Shozo Mori, Keiichi Kubota. Effects of branched‐chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(11): 819 doi: 10.1002/jhbp.830
|
| 32 |
Tao Zhang, Yaogang Zhang, Zihan Yang, Yuan Jiang, Li Sun, Dengliang Huang, Meiyuan Tian, Yinhong Shen, Jun Deng, Jing Hou, Yanyan Ma.
Echinococcus multilocularis
protoscoleces enhance glycolysis to promote M2 Macrophages through PI3K/Akt/mTOR Signaling Pathway
. Pathogens and Global Health 2023; 117(4): 409 doi: 10.1080/20477724.2022.2104055
|
| 33 |
Gebing Yao, Jikai Yin, Qing Wang, Rui Dong, Jianguo Lu. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2560650
|
| 34 |
Hengdong Qu, Junli Liu, Di Zhang, Ruoyan Xie, Lijuan Wang, Jian Hong. Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities. Cells 2023; 12(15): 1930 doi: 10.3390/cells12151930
|
| 35 |
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?. Cancers 2023; 15(12): 3161 doi: 10.3390/cancers15123161
|
| 36 |
Dezhi Li, Xianyi Cheng, Wei Zheng, Junhui Chen. <p>Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma</p>. Cancer Management and Research 2020; : 4923 doi: 10.2147/CMAR.S250094
|
| 37 |
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
|
| 38 |
Chenchen Wang, Ying Tong, Yankai Wen, Jie Cai, Han Guo, Lifeng Huang, Min Xu, Mingxuan Feng, Xiaosong Chen, Jianjun Zhang, Hailong Wu, Xiaoni Kong, Qiang Xia. Hepatocellular Carcinoma‐Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element‐Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth. Hepatology 2018; 68(5): 1833 doi: 10.1002/hep.30030
|
| 39 |
Somasekhara Derangula, Varalakshmi Kilingar Nadumane. Analysis of the Anticancer Mechanism of OR3 Pigment from Streptomyces coelicolor JUACT03 Against the Human Hepatoma Cell Line Using a Proteomic Approach. Cell Biochemistry and Biophysics 2024; 82(2): 1061 doi: 10.1007/s12013-024-01258-0
|
| 40 |
Fei-Fei Cai, Ya-Nan Song, Yi-Yu Lu, Yongyu Zhang, Yi-Yang Hu, Shi-Bing Su. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma. Aging 2020; 12(14): 14949 doi: 10.18632/aging.103554
|
| 41 |
Mengxiao Lu, Yingjie Wu, MinMing Xia, Yixin Zhang. The role of metabolic reprogramming in liver cancer and its clinical perspectives. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1454161
|
| 42 |
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai, Chuanyong Guo. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01629-4
|
| 43 |
Yiwei Xu, Xiaodong Hao, Yidan Ren, Qinchen Xu, Xiaoyan Liu, Shuliang Song, Yunshan Wang. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1063423
|
| 44 |
Ya‐Jie Hu, Xu Zhang, Hong‐Ming Lv, Yang Liu, Shi‐Ze Li. Protein O‐GlcNAcylation: The sweet hub in liver metabolic flexibility from a (patho)physiological perspective. Liver International 2024; 44(2): 293 doi: 10.1111/liv.15812
|
| 45 |
Xiaolong Chen, Zhixiong Xia, Yafeng Wan, Ping Huang. Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. Medicine 2021; 100(39): e27117 doi: 10.1097/MD.0000000000027117
|
| 46 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
|
| 47 |
Wenwei Liao, Jinpeng Du, Zhen Wang, Qingbo Feng, Mingheng Liao, Huixian Liu, Kefei Yuan, Yong Zeng. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma. International Journal of Cancer 2022; 151(3): 337 doi: 10.1002/ijc.34040
|
| 48 |
Rong Zhou, Wen Ni, Chao Qin, Yunxia Zhou, Yuqing Li, Jianping Huo, Lijuan Bian, Aijun Zhou, Jianming Li. A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02538-4
|
| 49 |
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma. PeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
|
| 50 |
Kanchan Vishnoi, Sandeep Kumar, Rong Ke, Ajay Rana, Basabi Rana. Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming. Current Opinion in Pharmacology 2022; 64: 102232 doi: 10.1016/j.coph.2022.102232
|
| 51 |
Zhongming Bao, Ming Yang, Yunhu Guo, Qi Ge, Huaguo Zhang. MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway. Cellular Signalling 2024; 123: 111366 doi: 10.1016/j.cellsig.2024.111366
|
| 52 |
Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei Gardini, Massimiliano Bonafè, Anna Maria Giudetti, Javier Egea. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/7512159
|
| 53 |
Shi-Lei Wang, Yu Wang, Lei Wu, Yuan-Yuan Cai, Zi-Chao Wang, Raphael N. Alolga, Lian-Wen Qi, Bin Li, Feng-Qing Huang. Paired Derivatization Approach with H/D-Labeled Hydroxylamine Reagents for Sensitive and Accurate Analysis of Monosaccharides by Liquid Chromatography Tandem Mass Spectrometry. Analytical Chemistry 2022; 94(8): 3590 doi: 10.1021/acs.analchem.1c04924
|
| 54 |
Shan Cong, shanshan Bai, Minghao Zhang, yanfang Bi, yu Wang, shi Jin, hui He. A study on metabolic characteristics and metabolic markers of gastrointestinal tumors. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2255369
|
| 55 |
Chao Liu, Renwei Huang, Han Yu, Yanju Gong, Peijie Wu, Quansheng Feng, Xia Li. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks. Phytomedicine 2022; 103: 154226 doi: 10.1016/j.phymed.2022.154226
|
| 56 |
Yuanyuan Zhao, Gang Ye, You Wang, Dan Luo. MiR-4461 Inhibits Tumorigenesis of Renal Cell Carcinoma by Targeting PPP1R3C. Cancer Biotherapy and Radiopharmaceuticals 2022; 37(6): 503 doi: 10.1089/cbr.2020.3846
|
| 57 |
Xinxu Min, Hao Cheng, Xiaofei Cao, Ziyang Chen, Xiaojin Zhang, Yunfan Li, Qian Mao, Bin Xue, Lei Fang, Li Liu, Zhengnian Ding. Heat shock protein A12A activates migration of hepatocellular carcinoma cells in a monocarboxylate transporter 4–dependent manner. Cell Stress and Chaperones 2022; 27(1): 83 doi: 10.1007/s12192-021-01251-z
|
| 58 |
Sheraz Ahmad Bhat, Zeenat Farooq, Hagar Ismail, Irene Corona-Avila, Md. Wasim Khan. Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231219434
|
| 59 |
Flora Yang, Leena Hilakivi-Clarke, Aurpita Shaha, Yuanguo Wang, Xianghu Wang, Yibin Deng, Jinping Lai, Ningling Kang. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology 2023; 78(5): 1602 doi: 10.1097/HEP.0000000000000005
|
| 60 |
Yunong Fu, Kaibo Yang, Kunjin Wu, Hai Wang, Qinglin Li, Fengping Zhang, Kun Yang, Qing Yao, Xiaohua Ma, Yujie Deng, Jingyao Zhang, Chang Liu, Kai Qu. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01393-6
|
| 61 |
Rosendo García-Carrillo, Francisco A. Molina-Pelayo, David Zarate-Lopez, Alejandro Cabrera-Aguilar, Bibiana Ortega-Domínguez, Mariana Domínguez-López, Natalia Chiquete-Félix, Adan Dagnino-Acosta, Gabriela Velasco-Loyden, Enrique Chávez, Luis Castro-Sánchez, Victoria Chagoya de Sánchez. An adenosine derivative promotes mitochondrial supercomplexes reorganization and restoration of mitochondria structure and bioenergetics in a diethylnitrosamine-induced hepatocellular carcinoma model. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56306-9
|
| 62 |
Mrigendra B. Karmacharya, Laith R. Sultan, Chandra M. Sehgal. Photoacoustic monitoring of oxygenation changes induced by therapeutic ultrasound in murine hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83439-y
|
| 63 |
Israa T. Ismail, Oliver Fiehn, Ashraf Elfert, Marwa Helal, Ibrahim Salama, Hala El-Said. Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues. Cancers 2020; 12(2): 484 doi: 10.3390/cancers12020484
|
| 64 |
Hiba S Al-Amodi, Hala F Kamel. Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC. Cureus 2024; doi: 10.7759/cureus.71968
|
| 65 |
Jian Xue, Feng Pan, Tengcong Long, Frank Shujie Hou. Glycosylated triptolide affords a potent in vivo therapeutic activity to hepatocellular carcinoma in mouse model. Medicinal Chemistry Research 2023; 32(2): 254 doi: 10.1007/s00044-022-03008-4
|
| 66 |
Jiabin Yang, Liangtang Zeng, Ruiwan Chen, Shangyou Zheng, Yu Zhou, Rufu Chen. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1076587
|
| 67 |
Romain Désert, Natalia Nieto, Orlando Musso. Dimensions of hepatocellular carcinoma phenotypic diversity. World Journal of Gastroenterology 2018; 24(40): 4536-4547 doi: 10.3748/wjg.v24.i40.4536
|
| 68 |
Chuanzong Zhao, Ben Wang, Enyu Liu, Zongli Zhang. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00622-w
|
| 69 |
Bahare Shokouhian, Babak Negahdari, Zahra Heydari, Mehdi Totonchi, Hamidreza Aboulkheyr Es, Abbas Piryaei, Ebrahim Mostafavi, Massoud Vosough. HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis. Cancer Science 2023; 114(4): 1337 doi: 10.1111/cas.15686
|
| 70 |
Delin Ma, Pengcheng Wei, Hengkang Liu, Jialing Hao, Zhuomiaoyu Chen, Yingming Chu, Zuyin Li, Wenzai Shi, Zhigao Yuan, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05854-9
|
| 71 |
Curtis C. Hughey, Elijah Trefts, Deanna P. Bracy, Freyja D. James, E. Patrick Donahue, David H. Wasserman. Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates. Journal of Biological Chemistry 2018; 293(30): 11944 doi: 10.1074/jbc.RA118.002568
|
| 72 |
Yongmei Li, Hao Zhuang, Xinran Zhang, Yuan Li, Yun Liu, Xianfu Yi, Guoxuan Qin, Wen Wei, Ruibing Chen. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma. Molecular & Cellular Proteomics 2018; 17(4): 607 doi: 10.1074/mcp.RA118.000586
|
| 73 |
Zhipeng Sun, Guangyang Chen, Liang Wang, Qing Sang, Guangzhong Xu, Nengwei Zhang. APEX1 promotes the oncogenicity of hepatocellular carcinoma via regulation of MAP2K6. Aging 2022; 14(19): 7959 doi: 10.18632/aging.204325
|
| 74 |
Marina Serra, Amedeo Columbano, Andrea Perra, Marta Anna Kowalik. Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma. Cancers 2020; 12(11): 3318 doi: 10.3390/cancers12113318
|
| 75 |
Hester van Mourik, Mengying Li, Sabine Baumgartner, Jan Theys, Ronit Shiri-Sverdlov. All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma. Biomedicines 2022; 10(10): 2351 doi: 10.3390/biomedicines10102351
|
| 76 |
Qi Wang, Juan Liu, Ziye Chen, Jingjing Zheng, Yunfang Wang, Jiahong Dong. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review. Biomedicine & Pharmacotherapy 2024; 170: 116021 doi: 10.1016/j.biopha.2023.116021
|
| 77 |
Se‐Lim Kim, Soo Teik Lee, In Suk Min, Young Ran Park, Ju Hyung Lee, Dae‐Ghon Kim, Sang‐Wook Kim. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer. Cancer Science 2017; 108(11): 2176 doi: 10.1111/cas.13389
|
| 78 |
Yile Hu, Yihao Xing, Gaolu Fan, Huaxia Xie, Qingzan Zhao, Ling Liu. L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS/NO/AKT-mediated glycolysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1391636
|
| 79 |
Yeliz Yılmaz, Ayşim Güneş, Hande Topel, Neşe Atabey. Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis. Journal of Gastrointestinal Cancer 2017; 48(3): 225 doi: 10.1007/s12029-017-9958-1
|
| 80 |
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World Journal of Gastroenterology 2018; 24(31): 3500-3512 doi: 10.3748/wjg.v24.i31.3500
|
| 81 |
Georgios A. Kaissis, Fabian K. Lohöfer, Marie Hörl, Irina Heid, Katja Steiger, Kim Agnes Munoz-Alvarez, Markus Schwaiger, Ernst J. Rummeny, Wilko Weichert, Philipp Paprottka, Rickmer Braren. Combined DCE-MRI- and FDG-PET enable histopathological grading prediction in a rat model of hepatocellular carcinoma. European Journal of Radiology 2020; 124: 108848 doi: 10.1016/j.ejrad.2020.108848
|
| 82 |
Huining Tian, Xiaoyu Zhu, You Lv, Yan Jiao, Guixia Wang. <p>Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect</p>. Cancer Management and Research 2020; : 5957 doi: 10.2147/CMAR.S258196
|
| 83 |
Quan-Hong Qin, Zhi-Qi Yin, Yan Li, Bao-Gui Wang, Ming-Fang Zhang. Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9. Biomedicine & Pharmacotherapy 2018; 97: 450 doi: 10.1016/j.biopha.2017.10.066
|
| 84 |
Yong-Zhuo Li, Jing Deng, Xiao-Dong Zhang, Dong-Yang Li, Li-Xi Su, Shan Li, Jian-Min Pan, Lan Lu, Jia-Qi Ya, Nuo Yang, Jing Zhou, Li-Hui Yang. Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1α signalling axis in liver cancer. Heliyon 2024; 10(11): e32288 doi: 10.1016/j.heliyon.2024.e32288
|
| 85 |
Yizhe Liu, Qili Shi, Yanfang Liu, Xinrong Li, Zhen Wang, Shenglin Huang, Zhiao Chen, Xianghuo He. Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer. Cancer Letters 2024; 602: 217190 doi: 10.1016/j.canlet.2024.217190
|
| 86 |
Fengmei Zhang, Jing Wu, Lei Zhang, Jian Zhang, Rui Yang. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy. Journal of Pharmaceutical and Biomedical Analysis 2024; 243: 116073 doi: 10.1016/j.jpba.2024.116073
|
| 87 |
Sapna Sharma, Jennifer Kriebel, Harald Grallert. Epigenetic regulation of glucose metabolism. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(4): 266 doi: 10.1097/MCO.0000000000000375
|
| 88 |
Haiying Xu, Lanqing Li, Shunshun Wang, Zijun Wang, Linghang Qu, Chunli Wang, Kang Xu. Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine 2023; 118: 154940 doi: 10.1016/j.phymed.2023.154940
|
| 89 |
Weizheng Wu, Kunming Wen. Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review). Oncology Reports 2022; 48(3) doi: 10.3892/or.2022.8365
|